Company
Radiopharm Theranostics Ltd
ASX:RAD
Radiopharm Theranostics is a clinical-stage biotech company revolutionizing cancer care through the development of first-in-class radiopharmaceuticals. The company is advancing a pipeline of distinct radiopharmaceutical technologies for novel oncology targets—avoiding "me-too" targets like Prostate-Specific Membrane Antigen (PSMA), Fibroblast Activation Protein (FAP) or Somatostatin Receptor 2 (SSTR2).
101 stories · page 5 of 6
Radar Iron to discuss the road to iron ore feasibility studies at upcoming One2One Forum in Sydney
Want to ask CEO's probing questions? Proactive Investors provides the forum. Next up in Sydney is Radar Iron, Norwest Energy, ZYL Limited, Latin Resources, and Northwest Resources.
Sheffield Resources, Radar Iron, Kidman Resources, Fortis Mining, Glory Resources gain in IPO review
With 19 resource IPO's hitting the ASX boards around one year ago - Proactive Investors Australia are here to provide a performance review over the turbulent 2011. Find out which companies investors are supporting, and selling.
Radar Iron identifies DSO iron ore targets at Jackson and Boondine projects
The news flow is about to ramp up for Radar's assets in the Yilgarn Iron Ore Province, with the drilling of up to 20 DSO targets at Johnston Range commencing in October, and a maiden JORC Resource from Die Hardy expected in November.